Small suspicious choroidal neoplasms commonly present a diagnostic challenge in primary eye-care clinics, where they are most likely to present. Differentiating benign from malignant choroidal neoplasms is essential for facilitating early diagnosis and treatment, potentially decreasing the risk of metastasis and vision loss in some cases. The purpose of this review is to describe the clinical, spectral-domain optical coherence tomography and fundus autofluorescence features of suspicious choroidal neoplasms in a case series of patients presenting to a primary eye-care clinic at the Veterans Health Administration, Cleveland, Ohio, USA.
Primary eye-care providers are likely to encounter patients with suspicious choroidal lesions during routine clinical examination. The choroid can be a harbour of malignant neoplasms, such as choroidal melanoma and metastasis. 1 Other benign choroidal lesions may have overlapping clinical features that mimic malignancies, many times precluding an accurate diagnosis and requiring consultation with a retinal or ocular oncology ophthalmologist. With access to high-resolution spectral-domain optical coherence tomography (SD-OCT), optometrists are able to evaluate microstructural retinal and choroidal changes, allowing better characterisation of suspicious choroidal lesions. SD-OCT is also used to perform enhanced-depth imaging OCT (EDI-OCT) to increase the resolution of structures posterior to the retinal pigment epithelial (RPE) layer, specifically the choroid and sclera, further expanding the ability to evaluate subretinal lesions. Fundus autofluorescence is another useful imaging tool for evaluating retinal changes associated with choroidal lesions. Fundus autofluorescence highlights the presence of lipofuscin, a clinical finding known to have strong association with malignant choroidal lesions. SD-OCT systems such as Topcon 3D OCT-2000 (Topcon Medical Systems, Inc., Oakland, New Jersey, USA) and Heidelberg Spectralis HRA+OCT (Heidelberg Engineering, Heidelberg, Germany) are equipped with fundus autofluorescence imaging, which is able to highlight areas of RPE distress caused by the underlying effects of invasive or spaceoccupying choroidal lesions. Combined analysis of SD-OCT and fundus autofluorescence, referred to as multimodal imaging, can enhance the evaluation process for suspicious choroidal lesions, possibly facilitating an earlier diagnosis and conversely, preventing false-positive referrals for benign choroidal lesions. Herein, we describe the clinical, SD-OCT and fundus autofluorescent features of small suspicious choroidal neoplasms and mimicking lesions, both benign and malignant, in a case series of patients presenting to a primary eye-care clinic at the Veterans Health Administration, Cleveland, Ohio, USA.
METHODS
A retrospective review was performed on selected cases of small choroidal neoplasms that presented between 2009 and 2015 to the Louis Stokes Cleveland Veterans Affairs Medical Centre in Cleveland, Ohio, USA. Ten cases were selected to demonstrate a broad range of choroidal neoplasms, including benign, suspicious and malignant classifications. Additionally, two non-choroidal-based lesions were chosen to represent lesions that can mimic choroidal melanoma and metastasis. Benign choroidal neoplasms were defined as those without any risk factors for growth. Suspicious choroidal neoplasms were classified based on the presence of any risk factors for growth: tumour thickness greater than 2.0 mm, subretinal fluid, symptoms, orange pigment and a margin less than or equal to 3.0 mm from the optic nerve. 2 Small choroidal melanomata were defined as those measuring less than 4.0 mm in thickness, with clinical findings indicative of malignancy and the diagnosis of which was confirmed by a retinal specialist or ophthalmologist specialising in ocular oncology. 3 All digital fundus photography was performed using the Topcon TRC-50 DX mydriatic retinal camera (Topcon Medical Systems, Inc.). The basal diameter of each choroidal neoplasm and distance from the optic nerve were measured using a ruler on the software provided with the Topcon TRC-50 DX camera. SD-OCT and fundus autofluorescence were performed through a dilated pupil using the Heidelberg Spectralis HRA+OCT (Heidelberg Engineering). When possible, thickness measurements of choroidal neoplasms were made using EDI-OCT imaging to identify the anterior and posterior surfaces of the choroidal neoplasm, demarcated by red segmentation lines. The anterior margin of the choroidal neoplasm was plotted automatically by the Spectralis OCT at Bruch's membrane. The posterior margin of the choroidal neoplasm was plotted manually at the location judged to be the interface between the hypo-reflective choroid and the hyper-reflective inner sclera, known as the choroid-scleral junction.
DISCUSSION

Multimodal imaging for choroidal neoplasms OCT IMAGING
SD-OCT has the ability to produce highresolution, cross-sectional images of choroidal neoplasms and any associated extrinsic effects they have upon the overlying retina; however, SD-OCT imaging of choroidal neoplasms can be precluded in instances where the size of the lesion is greater than the OCT imaging field, which approximates a scan depth of 1.8 to 2.3 mm and scan width of 9.0 mm, depending on the OCT system being used. 4 Therefore, SD-OCT may have limited clinical utility for imaging medium (4.0 to 8.0 mm thickness) and large (greater than 8.0 mm thickness) choroidal neoplasms; 3 however, the Collaborative Ocular Melanoma Study demonstrated 99 per cent diagnostic accuracy using Bscan ultrasonography, fluorescein angiography and clinical evaluation for medium to large choroidal melanomata, largely negating the need for diagnostic SD-OCT imaging in these patients. 5 Melanocytic choroidal neoplasms may also block the OCT signal beyond the anterior surface of the tumour, preventing measurement of the tumour thickness, as well as visualisation of OCT internal reflectivity of the neoplasm and choroidal vascular spaces. 6 In addition to detecting the extrinsic retinal changes produced by small choroidal tumours, such as the presence of subretinal fluid or retinal pigment epithelial detachment, SD-OCT analysis also enables an accurate method for measuring the thickness of choroidal neoplasms.
7 EDI-OCT imaging is the preferred OCT method for analysing choroidal neoplasms. EDI-OCT uses SD-OCT technology but moves the objective lens closer to the eye, which brings the peak OCT sensitivity toward the plane of the RPE, thereby increasing visibility of the choroid and inner sclera. EDI-OCT provides three to four micron resolutions of the retina and the choroid. 8 
FUNDUS AUTOFLUORESCENCE IMAGING
The presence of excessive intracellular RPE lipofuscin, sometimes viewed clinically as a confluence of orange pigment within the RPE layer, signifies potential malignancy of choroidal neoplasms. 9, 10 Fundus autofluorescent imaging can enhance identification of excessive RPE orange pigment in association with a suspicious choroidal neoplasm. 11 Fundus autofluorescence can be helpful in detecting subtle accumulations of orange pigment in choroidal neoplasms, especially in amelanotic lesions. When lipofuscin is exposed to intense blue light with a wavelength of 488 nm, it naturally autofluoresces. 12 The RPE houses lipofuscin pigment in its normal physiological state, resulting in a diffuse, homogenous and background autofluorescence of the RPE layer throughout the posterior pole. Variation in the intensity of autofluorescence is judged by comparing it to the background fundus autofluorescence and can be described as hypo-, iso-or hyperautofluorescent. The macula has a natural relative hypo-autofluorescence compared to the background autofluorescence due to absorption of the excitation light by lutein and zeaxanthin pigments. Hypoautofluorescent areas signify RPE atrophy, resulting from a loss of autofluorescing lipofuscin. Likewise, no autofluorescence is observed in structures in which lipofuscin is not present, such as the optic nerve head, or where the excitation light for fundus autofluorescence is blocked, as with retinal blood vessels. Early RPE damage results in hyper-autofluorescence and late damage to the RPE can be seen as hypoautofluorescence due to significant or complete loss of the RPE. 13 These principles are important when evaluating the autofluorescent characteristics of choroidal neoplasms, which can have extrinsic effects upon the overlying RPE and retina, thereby producing variations in the background autofluorescent signal in the posterior pole.
Benign choroidal naevus BACKGROUND AND CLINICAL CHARACTERISTICS
Choroidal naevus is a common, benign intraocular neoplasm that develops from melanocytic cells derived from the embryologic neural crest. 14 Choroidal naevi are pigmented, subretinal neoplasms with clearly defined margins and are blue-grey or greengrey ( Figure 1A) . 15 Up to 10 per cent of choroidal naevi may be amelanotic, being more whitish (Figure 2A) . 16 Most choroidal naevi are small and minimally elevated but can measure up to 5.0 mm in basal diameter and 3.0 mm in thickness. Over time, choroidal naevi can exhibit chronic features of atrophy or hyperplasia of the RPE and drusen. 3 Although benign in nature, a choroidal naevus can rarely transform into a choroidal melanoma, with an estimated risk of one in 8,000 cases. 1 Despite the rare occurrence, choroidal naevi are frequently monitored by primary eye-care providers for malignant transformation.
ADVANCED IMAGING CHARACTERISTICS
SD-OCT evaluation of choroidal naevi should include assessment of the lesion and any microstructural changes that can occur upon the overlying RPE and retina. The OCT reflectivity of a choroidal naevus is variable and may be limited to the anterior surface, with approximately 60 per cent appearing hypo-reflective, 30 per cent iso-reflective and 10 per cent hyper-reflective. 1 Variations in the choroidal naevus OCT reflectance pattern may depend upon the integrity of the RPE layer, which can be affected by the underlying choroidal naevus and its level of pigmentation.
1,17 EDI-OCT of highly pigmented naevi shows a reflective band with complete posterior shadowing ( Figure 7B ). 18 Amelanotic naevi tend to have a homogenous appearance with medium reflectivity and no posterior shadowing ( Figure 2B ).
Evaluating autofluorescence of choroidal naevi includes assessment of the intrinsic autofluorescence of the neoplasm itself in addition to the autofluorescence characteristics of the overlying RPE. Shields, Perondini and Bianciotto 19 evaluated 64 eyes with choroidal naevi and found 56 per cent were intrinsically hypo-autofluorescent, 19 per cent had no change in background autofluorescence and 25 per cent were hyper-autofluorescent. RPE hyperplasia, atrophy and fibrous metaplasia overlying a choroidal naevus exhibit hypo-autofluorescence, which suggests chronic RPE changes consistent with a non-growing neoplasm. If retina changes are more recent, RPE hyperplasia and fibrous metaplasia may be hyper-autofluorescent, signaling the early stages of RPE failure and lipofuscin buildup ( Figure 6C ). Drusen, another sign of a slow or non-growing choroidal naevus, may display a ring-shaped hyper-autofluorescence. Figures 1C and 2C show a normal pattern of background autofluorescence with no corresponding areas of hyper-or hypo-autofluorescence.
Suspicious choroidal naevus BACKGROUND AND CLINICAL CHARACTERISTICS
Suspicious choroidal naevi can take on several overlapping clinical features of a small choroidal melanoma, including tumour size, colour, location and presence of subretinal fluid and orange pigment (Figures 3 to 7) . Therefore, differentiating a suspicious choroidal naevus from a small choroidal melanoma should employ both the funduscopic evaluation along with specialised ancillary imaging, including fluorescein angiography, B-scan ultrasonography, fundus autofluorescence and SD-OCT. Choroidal naevi may develop suspicious characteristics that can be predictive of their conversion to a choroidal melanoma. Eight characteristics of a choroidal melanocytic lesion that are predictive of neoplasm growth have been identified. There is slight elevation of the overlying retina but the retinal pigment epithelium and outer retina appear to be unaffected. (C) Normal background autofluorescent signal in the area of the choroidal naevus, consistent with minimal to no effect of the choroidal naevus upon the retinal pigment epithelium. Due to the absence of any risk factors for growth, this patient was monitored in our primary eye-care clinic.
Neoplastic
Margin less than or equal to 3.0 mm from the optic disc 6. Hollow intrinsic acoustic signal of the neoplasm using Ultrasonography 7. Absence of a surrounding depigmented
Halo and 8. Absence of overlying Drusen. 16, 20 These factors can be remembered with the mnemonic -TFSOM-UHHD -'To find small ocular melanoma using helpful hints daily'. Typically, a small melanoma displays two or three of these factors. 21 Naevi with no risk factors carry a three per cent risk for growth over five years, are classified as benign and require less frequent evaluation. 22 The presence of three or more risk factors is associated with a more than 50 per cent chance of tumour growth in five years. 16, 22 Features that lower the likelihood of a diagnosis of choroidal melanoma should be considered when evaluating suspicious choroidal naevi. Approximately 98 per cent of naevi have overlying drusen (Figures 3A, 4A and 5A), an indication of slow growth and the drusen appear similar to those seen in macular degeneration. 1, 15 Funduscopic clues, such as a lack of drusen, are a predictive risk factor for choroidal neoplastic growth based on the Collaborative Ocular Melanoma Study (COMS). 23 Another factor that may be predictive of stability with less risk for growth into a melanoma is presence of a halo naevus, which makes up about five per cent of all choroidal naevi. 24 A halo naevus refers to a pigmented choroidal naevus surrounded by a circular band of depigmentation ( Figure 5A ). A reverse halo naevus is a depigmented choroidal naevus surrounded The patient presented with one risk factor for growth: margins less than 3.0 mm from the optic disc. The patient was monitored by a retinal specialist every six months due to size of neoplasm and proximity to the macula.
by a darker circular band ( Figure 6A ). In some cases and depending on the number of risk factors present, the ophthalmologist may elect to monitor suspicious choroidal neoplasms that show signs of stability to assess their growth pattern, in which case, clinical observation becomes part of the diagnostic process.
ADVANCED IMAGING CHARACTERISTICS
SD-OCT and autofluorescence can be used in conjunction with clinical examination to evaluate suspicious choroidal neoplasms. Several factors such as basal diameter, height of lesion, drusen, orange pigment and presence of subretinal fluid can be used to determine the likelihood of growth. Drusen are typically visible with funduscopic evaluation, but can also be detected with SD-OCT, in which they are seen as focal hyper-reflective elevations of the RPE with an intact underlying Bruch's membrane ( Figure 4B ). Presence of subretinal fluid is a strong risk factor for growth; however, subtle subretinal fluid associated with a malignant lesion can be clinically difficult to assess. Furthermore, a clinical examination cannot distinguish active subretinal fluid associated with a malignant lesion from chronic retinal changes which are associated with a longstanding dormant neoplasm. 25 Chronic OCT pattern is indicated by the presence of overlying retinal thinning or intraretinal cysts. Active OCT pattern typically presents with a localised serous retinal detachment. 25 Therefore, SD-OCT enables detection of subretinal fluid in addition to helping distinguish active subretinal fluid from chronic suspicious choroidal lesions. Figure 6C ). This can be used to differentiate such neoplasms from benign choroidal naevi in which there is a lack of hyper-autofluroescence. 27 However, benign choroidal neoplasms with secondary RPE changes, such as drusen or pigment epithelium detachment ( Figure 7C ) are likely to show faint hyper-autofluorescence ( Figure 7D ). 10 
Choroidal melanoma BACKGROUND AND CLINICAL CHARACTERISTICS
Choroidal melanoma is the most common primary malignant intraocular neoplasm in adults. 14, 28 Small choroidal melanomata, defined as those measuring less than 3.0 mm in thickness, are likely to present to a primary eye-care clinic. 2 In fact, compared to medium and large choroidal melanomata, a greater proportion of small tumours is asymptomatic and most likely to be detected during routine fundus examination. A large study showed that 35 per cent of choroidal melanomata are considered small, with 30 per cent of those demonstrating significant growth over a five-year period, stressing the need for detection during primary eye-care examination. 29 When first observed, small choroidal melanomata may have mimicking features of choroidal naevi that can confound the diagnosis. 30 Immediate diagnosis of small choroidal melanoma is critical as size is the greatest prognostic factor for tumourrelated death and tumour growth can be rapid. 31 Tumour growth over a short period of time is considered a hallmark of choroidal melanoma. [32] [33] [34] This can be One risk factor of thickness >2.00 mm in addition to, close proximity to the macula, large basal dimensions, elevated profile and small retinal pigment epithelial detachment. This patient is being monitored by a retinal specialist every six months.
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contrasted with minimal growth of choroidal naevi, which can occur over 15 years. 35 Choroidal melanoma usually presents as a solitary, dome-shaped, subretinal mass that more commonly originates at the posterior pole.
36
Patients with more anteriorly located tumours are associated with increased risk of mortality. 37 Choroidal melanomata can be pigmented, partially pigmented, or amelanotic with orange pigment frequently overlying the tumour ( Figure 8A ).
14 In addition to documented growth, increased thickness of a choroidal melanoma is associated with higher risk for metastasis and mortality.
37 Each 1.0 mm increase in thickness adds approximately five per cent of increased risk for metastatic disease at 10 years. 7 When analysing suspicious choroidal neoplasms, the mnemonic TFSOM-UHHD can assist in identifying risk factors predictive of a choroidal melanoma. Based on Shields, Furuta and Berman, 16 patients who present with three risk factors had a five-fold risk compared with a neoplasm without any risk factors and one with seven risk factors had a 21-fold greater risk for growth. 16 
ADVANCED IMAGING CHARACTERISTICS
The role of SD-OCT and autofluorescence in diagnosing small choroidal melanomata is evolving but both imaging techniques reveal specific clinical features that may help make the distinction between a suspicious choroidal naevus and a choroidal melanoma. Although SD-OCT is limited by a small imaging field of view and poor light penetrance in highly pigmented tumours, it can be of great value for discerning microstructural retinal changes associated with choroidal neoplasms and in some cases enables precise thickness measurements. SD-OCT can be vital in detection of sub-clinical subretinal fluid; a significant risk factor for metastasis. 38 In small choroidal tumours, SD-OCT may supplement B-scan ultrasonography, which has a lower axial resolution (approximately 1.5 mm) and poorer sensitivity for detecting subretinal fluid.
39 EDI-OCT of a choroidal melanoma usually shows a domed shaped, smooth-surface with active subretinal fluid that often results in a hazy, thickened band along the underside of the detached retina, referred to as shaggy photoreceptors. These are thought to represent oedematous photoreceptors or macrophages with lipofuscin that form sub-acutely from the extrinsic deleterious effects of the underlying choroidal melanoma or metastasis. 40 In cases of marked subretinal fluid, where the retina is locally detached, special attention should be paid to the integrity of the overlying retina to provide clues about the age of the choroidal lesion. If SD-OCT imaging reveals diffuse subretinal fluid with an otherwise normal overlying retina, a more recent localised retinal detachment secondary to rapid tumour growth is suspected. Conversely, subretinal fluid that leads to retinal detachment with an overlying retina with thinning, intraretinal cysts and RPE thickening, is suggestive of a chronic OCT pattern more consistent with a slow growing choroidal neoplasm ( Figure 9B ). 25 Background autofluorescence is very likely to be disrupted in a choroidal melanoma. Medium and large choroidal melanomata may develop areas of increased pigmentation and fibrous metaplasia that hyper-autofluoresces. 10 Fundus autofluorescent imaging can highlight accumulations of orange pigment that are seen as focal or diffuse areas of hyper-autofluorescence ( Figure 8D ). Hypo-autofluorescence may be seen in areas where superficial retinal damage has occurred, often due to atrophy. 11 In an analysis of 51 eyes, Shields, Bianciotto and Perondini 11 found that choroidal melanomata displayed hypoautofluorescence in 39 per cent of cases, iso-autofluorescence in six per cent and 
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Clinical and Experimental Optometry 100.6 November 2017 © 2017 Optometry Australia hyper-autofluorescence in 55 per cent of cases. Although many choroidal melanomata can be identified based upon their large size, 30 per cent of choroidal melanomata are less than 3.0 mm in thickness, a subgroup that is more likely to have overlapping clinical features with suspicious choroidal naevi. Compared with choroidal naevi, small choroidal melanomata show increased thickness, presence of subretinal fluid, orange pigment and RPE atrophy. 18 Multimodal imaging can make the diagnostic process even more precise using autofluorescence to identify the tumour area and intrinsic autofluorescent properties, presence of lipofuscin and drusen, while SD-OCT may reveal subclinical subretinal and intraretinal fluid. Furthermore, precise documentation of tumour growth, a heralding sign of choroidal melanoma, is possible using EDI-OCT with small choroidal tumours, the anterior and posterior margins of which are visualised. Measuring choroidal neoplasm thickness with EDI-OCT is more accurate than ultrasonography, which tends to overestimate tumour thickness by up to 50 per cent. 8 
Choroidal metastasis BACKGROUND AND CLINICAL CHARACTERISTICS
The choroid is the most common ocular site for metastatic disease. 1, 41 The fenestrated choroidal vascular plexus accounts for the highest blood flow rate by weight of any tissue in the body. 42 The blood vessels that supply the choroid, mainly the posterior ciliary arteries, are localised to the posterior pole and are thought to enable greater access of tumour emboli into the choroid. 43, 44 Approximately 66 per cent of patients with choroidal metastasis have a prior history of cancer, most commonly the breast in women and the lungs in men. 45 Choroidal metastasis can present as isolated ( Figure 10A ) or multiple nonpigmented lesions that may be associated with overlying pigment epithelial alterations. Multiple choroidal metastases are more frequently observed in women than in men. 46 Most choroidal metastases are small with mean thickness of 3.0 mm and are located in the macular or paramacular region. 47 Visual acuity is commonly reduced in these patients. 46 Choroidal metastasis is typically diagnosed based upon the patient's medical history, clinical appearance and fluorescein angiographic findings. Recently, fundus autofluorescence and SD-OCT have been used to improve the diagnostic evaluation of choroidal metastasis.
ADVANCED IMAGING CHARACTERISTICS
The small size and posterior location of choroidal metastasis make it ideal for study with SD-OCT. Similar to other choroidal neoplasms, SD-OCT can be used to visualise the extrinsic retinal effects and intrinsic tumour characteristics of the choroidal metastasis. SD-OCT features of choroidal metastases include an undulating anterior tumour profile with a similar effect on the neurosensory retina and RPE, as well as areas of exudative subretinal fluid ( Figure 10B ). 1 In fact, Shields, Pelligrini and Ferenczy 48 have identified this undulating contour as a key differentiating SD-OCT feature of choroidal metastasis, referring to it as a lumpy-bumpy appearance ( Figure 10B) , which is distinctly different from the dome-shaped elevations seen with a suspicious choroidal naevus and choroidal melanoma. Many reports have outlined common SD-OCT findings, as well as their roles in detection and diagnosis of choroidal metastasis. Torres, Brugnoni and Kaiser 6 reported a series of EDI-OCT images in patients with small choroidal metastatic tumours that were visualised on examination but were undetectable by Bscan ultrasonography. Witkin, Fisher and Shields 49 reported a patient with a nonobvious choroidal metastasis on clinical examination and ultrasound, which was detected by EDI-OCT. Many secondary changes that occur with choroidal metastases are detected with SD-OCT, including retinal oedema, pigment epithelial atrophy, cystoid retinal degeneration leading to retinoschisis and tumour invasion of the neurosensory retina. 49 Pigment clumping overlying the tumour is also evident with SD-OCT imaging and appears as highly reflective foci with attachments to the RPE or that extend to the outer retina. 13 Finally, Shields, Shields and Gross 46 reported a high rate of neurosensory retinal detachment and RPE alterations associated with choroidal metastasis, specifically the presence of subretinal fluid in 73 per cent of their 520 eyes with uveal metastases and 57 per cent with associated RPE alterations.
Autofluorescent imaging of choroidal metastases typically shows variable autofluorescent patterns and is helpful for delineating the tumour margins. By highlighting the tumour margins, autofluorescent imaging can be used to detect basal tumour growth, especially in hypopigmented choroidal metastases, where the borders are indistinct with the adjacent retina. Hyper-autofluorescence is common in areas of hyperpigmentation and subretinal fluid. 13, 50 Metastatic tumours that are amelanotic and without any overlying pigmentation ( Figure 10A ) typically are hypo-autofluorescent ( Figure 10C ) on autofluorescent imaging. Additionally, hypo-autofluorescence can be present, if there is complete destruction of the RPE. 13 
Lesions that mimic choroidal melanoma
Multimodal imaging can provide definitive diagnostic information in certain nonchoroidal lesions by demonstrating that a lesion is not originating from the choroid. Lesions that may be misdiagnosed as choroidal neoplasms include sclerochoroidal calcification and congenital hypertrophy of the RPE. Clinically, these lesions can simulate a choroidal melanoma or metastasis, leading to uncertainty in diagnosis. In a study of 12,000 patients referred for diagnosis of a choroidal melanoma over a 25-year period, 1,739 were found to have a pseudomelanoma. Of these, 12 patients (D) Fundus autofluorescence shows generalised marked hypo-autofluorescence of the choroidal melanoma and retina, consistent with OCT findings that demonstrate severe retinal pigment epithelial thinning and loss. Intense confluent areas of hyperautofluorescence are seen overlying the hypo-autofluorescent area and correspond to accumulations of orange pigment. Additionally, the subretinal fluid that has settled inferior to the choroidal melanoma demonstrates a mild, diffuse hyper-autofluorescence. Due to the presence of orange pigment, location of the tumour margin at the optic disc, symptoms of blurred vision in the left eye and subretinal fluid, this patient was referred to an oncological ophthalmologist. A diagnosis of small choroidal melanoma was confirmed and treated with I 125 plaque brachytherapy.
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Clinical and Experimental Optometry 100.6 November 2017 © 2017 Optometry Australia had sclerochoroidal calcification and 108 had congenital hypertrophy of the RPE. 51 Herein, we review the multimodal imaging characteristics of these nonchoroidal lesions.
Sclerochoroidal calcification BACKGROUND AND CLINICAL CHARACTERISTICS
Sclerochoroidal tumours are calcifications confined to the sclera that can mimic the appearance of metastatic and amelanotic choroidal tumours. Sclerochoroidal calcification can be a manifestation of hypercalcaemia from conditions that elevate serological calcium levels (for The clinical appearance of a sclerochoroidal calcification is a whitish-yellow subretinal plaque, which can be isolated or multifocal, unilateral or bilateral and flat or elevated ( Figure 11A ).
ADVANCED IMAGING CHARACTERISTICS
As the area of scleral calcification progresses, it eventually displaces the overlying choroidal and retinal tissue. EDI-OCT can reveal the extent of anterior displacement of the overlying tissues, seen as choroidal thinning at the apex of the tumour. 53 EDI-OCT of sclerochoroidal calcification reveals an illdefined subchoroidal lesion, the lateral margins of which cannot be readily distinguished but often a clear anterior margin remains continuous with the choroid-scleral junction line ( Figure 11B ). This distinctive continuation of the choroid-scleral junction with the anterior margin of the lesion may help to differentiate the scleral origin of sclerochoroidal calcification from a choroidal tumour. Another OCT characteristic of sclerochoroidal calcification is the dense posterior shadowing cast from the anterior surface of the lesions. The mass effect on the overlying tissues may result in an undulating effect on the RPE and retinal layers. Shields, Manalac and Das 52 have described four SD-OCT patterns of sclerochoroidal calcification 'tumours' that reflect the shape of the sclerochoroidal calcification and its effect on the overlying retina. The patterns include flat, rolling, rocky-rolling and table mountain. 52 In general, sclerochoroidal calcification has normal background autofluorescence overlying the lesion, consistent with minimal degenerative effects of the choroid, overlying pigment epithelium and retina often confirmed by the SD-OCT imaging ( Figure 11C ).
Key differential findings that distinguish sclerochoroidal calcification from choroidal neoplasms include a scleralbased lesion evident on EDI-OCT and absence of exudative signs within the overlying retina that is common with choroidal melanoma and metastasis. Ocular oncology referral centres cite sclerochoroidal calcification as a commonly misdiagnosed condition, despite its classic clinical presentation and distinct SD-OCT features that reveal its scleral and not choroidal origin. 52 
Congenital hypertrophy of the RPE BACKGROUND AND CLINICAL CHARACTERISTICS
Congenital hypertrophy of the RPE is a benign, flat and pigmented lesion located at the level of the RPE ( Figure 12A ). 54 Some lesions also have window-like defects called lacunae. Lacunae are associated with pigment epithelial atrophy and loss. 55 Congenital hypertrophy of the RPE is often an incidental finding during a routine eye 
ADVANCED IMAGING CHARACTERISTICS
Imaging modalities such as SD-OCT and fundus autofluorescence can easily distinguish a congenital hypertrophy of the RPE from a choroidal melanoma. SD-OCT shows absence or thinning of the outer retinal layer and complete loss of the photoreceptor layer. In some cases, SD-OCT will reveal the presence of a subretinal cleft ( Figure 12B ). A subretinal cleft is seen as a broad vacant space that corresponds with an absent outer retina but with an intact inner retina. This finding should not be misinterpreted as subretinal fluid with associated anterior displacement of the overlying retina. 54 EDI-OCT shows normal choroidal thickness and appearance. It is important to note that a congenital hypertrophy of the RPE lies at the level of RPE with normal choroid thickness and appearance, a key feature that can be used to distinguish from a choroidal melanoma.
Fundus autofluorescent imaging of a congenital hypertrophy of the RPE shows characteristic hypo-autofluorescence due to the absence of lipofuscin in the enlarged and heavily pigmented epithelial cells ( Figure 12C ). Lacunae can appear isoautofluorescent or hyper-autofluorescent. 54 
CONCLUSIONS
Primary eye-care clinicians are poised to make more accurate and timely diagnoses of choroidal neoplasms using multimodal imaging techniques to improve their management decisions. A thorough clinical evaluation of choroidal tumours, enhanced by autofluorescent imaging and guided by a detailed analysis of SD-OCT findings of the tumour, RPE and retina, can enable primary-care optometrists to better characterise, categorise and diagnose suspicious choroidal lesions, thereby expediting the referral process, when malignancy is evident. Table 1 highlights the spectrum of clinical and multimodal imaging findings for choroidal neoplasms and mimicking lesions and can help prevent false-positive referrals for benign choroidal tumours, which can cause an unnecessary emotional burden on the patient.
